GENEREX BIOTECHNOLOGY CORPORATION | 0,02 Euro | 0,000 0 % | |
| WKN: 922012 ISIN: US3714851033 Ticker-Symbol: GB8 | Stuttgart | 17.05.13 | 08:10 Uhr |
Branche BiotechnologieAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 03.04. | Generex Comments on Results of Stockholders' Meeting | 75 | PR Newswire | |
| WORCESTER, Mass. and TORONTO, April 3, 2013 /PRNewswire/ --Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today commented on the results of the meeting of the Company's stockholders... Mehr lesen zu: Generex Comments on Results of Stockholders' Meeting | ||||
| 11.03. | GENEREX BIOTECHNOLOGY CORP - 10-Q, Quarterly Report | 25 | SEC Filings | |
| 07.02. | Generex Touts Pipeline Potential of Antigen Express Subsidiary | 78 | PR Newswire | |
| WORCESTER, Mass. and TORONTO, Feb. 7, 2013 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today provided an overview of the current pipeline and potential of its... Mehr lesen zu: Generex Touts Pipeline Potential of Antigen Express Subsidiary | ||||
| 05.02. | Generex Biotechnology Corporation (OTC:GNBT) Cools Down After Spike | 13 | HotStocked.com | |
| 31.01. | Generex Biotechnology Corp (OTC:GNBT) Spikes on Therapies Outlook | 22 | HotStocked.com | |
| 31.01. | Generex Points to Potential of Antigen Express Technology Platform beyond Its AE37 Breast Cancer Vaccine | 49 | PR Newswire | |
| WORCESTER, Mass. and TORONTO, Jan. 31, 2013 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today explained the potential of the technology platform used as the basis... Mehr lesen zu: Generex Points to Potential of Antigen Express Technology Platform beyond Its AE37 Breast Cancer Vaccine | ||||
| 31.01. | Facebook Indicating Lower Open As Profit Dips - Top Volume OTC Stocks Thursday: Generex Biotechnology, Echo Automotive, Augme Technologies, Swingplane Ventures, AMR Corp | 93 | PR Newswire | |
| LONDON, January 31, 2013 /PRNewswire/ --
Shares in Facebook were looking to open lower on the Nasdaq this morning with shares trading pre market around 3 pcnt lower on Thursday. Investments into... Mehr lesen zu: Facebook Indicating Lower Open As Profit Dips - Top Volume OTC Stocks Thursday: Generex Biotechnology, Echo Automotive, Augme Technologies, Swingplane Ventures, AMR Corp | ||||
| 31.01. | Generex: Research For Sale On The Cheap | 18 | Seeking Alpha | |
| 30.01. | Generex Provides an Overview of its Cancer Immunotherapy Product, AE37, and Potential in Early Breast Cancer Given Current and Potential Future Therapies | 61 | PR Newswire | |
| WORCESTER, Mass. and TORONTO, Jan. 30, 2013 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today provided an overview on the early breast cancer competitive status... Mehr lesen zu: Generex Provides an Overview of its Cancer Immunotherapy Product, AE37, and Potential in Early Breast Cancer Given Current and Potential Future Therapies | ||||
| 29.01. | Generex Announces Details of Investor Conference Call | 43 | PR Newswire | |
| WORCESTER, Mass. and TORONTO, Jan. 29, 2013 /PRNewswire/ --Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) previously announced that Company management has scheduled an investor... Mehr lesen zu: Generex Announces Details of Investor Conference Call | ||||
| 24.01. | Generex submits oral insulin Phase III trial dossier to Indian government | 10 | Pharma Bus Review | |
| 23.01. | Generex Oral-lyn' Phase III Dossier Submitted To Indian Government For Marketing Approval | 65 | PR Newswire | |
| WORCESTER, Mass. and TORONTO, Jan.23, 2013 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that it has been advised by its Indian... Mehr lesen zu: Generex Oral-lyn' Phase III Dossier Submitted To Indian Government For Marketing Approval | ||||
| 14.01. | Generex Biotechnology Corp. (OTC:GNBT) Regains on Expected Business Status Update | 12 | HotStocked.com | |
| 11.01. | Generex Announces Investor Conference Call | 61 | PR Newswire | |
| WORCESTER, Mass. and TORONTO, Jan. 11, 2013 /PRNewswire/ --Generex Biotechnology Corporation (OTCBB: GNBT) today announced that Company management has scheduled an investor conference call for Thursday... Mehr lesen zu: Generex Announces Investor Conference Call | ||||
| 09.01. | Dead Cat Generex Biotechnology Corp. (OTC:GBNT) Bounces | 12 | HotStocked.com | |
| 14.12. | XFRA FRA:Deletion of Instruments from XETRA - 14.12.2012-015 | 615 | Xetra Newsboard | |
| The following instruments on XETRA do have their last trading day on
14.12.2012
Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am
14.12.2012
Nr. ISIN Börsenkürzel Name Land... Mehr lesen zu: XFRA FRA:Deletion of Instruments from XETRA - 14.12.2012-015 | ||||
| 13.12. | Generex Biotechnology Corporation (OTC:GNBT) on a Highway to SubPennyLand | 26 | HotStocked.com | |
| 11.12. | Generex Announces $750,000 Capital Investment | 89 | PR Newswire | |
| WORCESTER, Mass.and TORONTO, Dec. 11, 2012 /PRNewswire/ --Generex Biotechnology Corporation (the "Company" or "Generex") (www.generex.com) (OTCBB: GNBT) today announced that it entered into a securities... Mehr lesen zu: Generex Announces $750,000 Capital Investment | ||||
| 13.11. | Generex Provides Update on Company Initiatives Including the AE37 Breast Cancer Vaccine Program | 102 | PR Newswire | |
| WORCESTER, Mass. and TORONTO, Nov. 13, 2012 /PRNewswire/ --Generex Biotechnology Corporation (OTCBB:GNBT) today provided the following update on company initiatives.
Antigen Express, Inc. (www.antigenexpress.com)... Mehr lesen zu: Generex Provides Update on Company Initiatives Including the AE37 Breast Cancer Vaccine Program | ||||
| 20.09. | Generex Management Provides Update to Stockholders | 60 | PR Newswire | |
| WORCESTER, Mass.and TORONTO, Sept. 20, 2012 /PRNewswire/ -- Generex Biotechnology Corporation (OTCBB:GNBT) (www.generex.com) today released the following letter to its stockholders.
To... Mehr lesen zu: Generex Management Provides Update to Stockholders | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| EVOTEC | 2,818 | +0,07 % | Evotec-Aktie: Kursziel bei 3,50 Euro? |
| MEDIGENE | 0,937 | -6,11 % | Medigene-Aktie feiert Studienergebnisse mit EndoTAG |
| CELL THERAPEUTICS | 0,877 | -1,13 % | Cell Therapeutics to Present at Upcoming Investor Conferences |
| AGENNIX | 0,115 | -4,17 % | DGAP-DD: Agennix AG (deutsch) |
| MOLOGEN | 14,15 | +2,50 % | MOLOGEN AG weitet Forschungs- und Entwicklungsaktivitäten im ersten Quartal aus |
